BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL

被引：6
|
作者：
Sandhu, Roopinder K. [1 ]
Ezekowitz, Justin [1 ]
Andersson, Ulrika [1 ]
Alexander, John [1 ]
Granger, Christopher [1 ]
Halvorsen, Sigrun [1 ]
Hanna, Michael [1 ]
Hijazi, Ziad [1 ]
Jansky, Petr [1 ]
Lopes, Renato [1 ]
Wallentin, Lars [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60284-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1270M-07
引用
下载
收藏
页码：A284 / A284
页数：1
相关论文
共 50 条
  • [31] Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (vol 4, e002015, 2015)
    Rao, M. P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (04):
  • [32] Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
    Melloni, C.
    Dunning, A.
    Granger, C. B.
    Thomas, L.
    Khouri, M.
    Garcia, D. A.
    Hylek, E. M.
    Wallentin, L.
    Gersh, B. J.
    Douglas, P. S.
    Alexander, J. H.
    Lopes, R. D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 234 - 234
  • [33] Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
    Melloni, Chiara
    Dunning, Allison
    Granger, Christopher B.
    Thomas, Laine
    Khouri, Michel G.
    Garcia, David A.
    Hylek, Elaine M.
    Hanna, Michael
    Wallentin, Lars
    Gersh, Bernard J.
    Douglas, Pamela S.
    Alexander, John H.
    Lopes, Renato D.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12): : 1440 - +
  • [34] Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
    Vinereanu, Dragos
    Lopes, Renato D.
    Mulder, Hillary
    Gersh, Bernard J.
    Hanna, Michael
    de Barros e Silva, Pedro G. M.
    Atar, Dan
    Wallentin, Lars
    Granger, Christopher B.
    Alexander, John H.
    STROKE, 2017, 48 (12) : 3266 - 3273
  • [35] Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
    Al-Khatib, Sana M.
    Thomas, Laine
    Wallentin, Lars
    Lopes, Renato D.
    Gersh, Bernard
    Garcia, David
    Ezekowitz, Justin
    Alings, Marco
    Yang, Hongqui
    Alexander, John H.
    Flaker, Gregory
    Hanna, Michael
    Granger, Christopher B.
    EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2464 - 2471
  • [36] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
    Easton, J. Donald
    Lopes, Renato D.
    Bahit, M. Cecilia
    Wojdyla, Daniel M.
    Granger, Christopher B.
    Wallentin, Lars
    Alings, Marco
    Goto, Shinya
    Lewis, Basil S.
    Rosenqvist, Marten
    Hanna, Michael
    Mohan, Puneet
    Alexander, John H.
    Diener, Hans-Christoph
    LANCET NEUROLOGY, 2012, 11 (06): : 503 - 511
  • [37] Polypharmacy and the Impact of Apixaban on Clinical Events in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
    Focks, Jeroen Jaspers
    Brouwer, Marc A.
    Wojdyla, Daniel M.
    Tomas, Laine
    Lopes, Renato D.
    Hanna, Michael
    Lanas, Fernando
    Xavier, Denis
    Husted, Steen
    Wallentin, Lars
    Alexander, John H.
    Granger, Christopher B.
    Verheugt, Freek W.
    CIRCULATION, 2015, 132
  • [38] Apixaban versus warfarin in patients with atrial fibrillation and valvular heart disease: findings from the ARISTOTLE study
    Avezum, A.
    Lopes, R. D.
    Schulte, P. J.
    Lanas, F.
    Hanna, M.
    Pais, P.
    Erol, C.
    Diaz, R.
    Granger, C. B.
    Alexander, J. H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 809 - 809
  • [39] Clinical outcomes in patients with atrial fibrillation and echocardiographic risk factors for stroke anticoagulated with apixaban or warfarin
    Vinereanu, D.
    Lopes, R. D.
    Mulder, H.
    Gersh, B. J.
    Hanna, M.
    De Barros E Silva, P. G. M.
    Atar, D.
    Wallentin, L.
    Granger, C. B.
    Alexander, J. H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 776 - 776
  • [40] Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Alings, Marco
    Atar, Dan
    Aylward, Philip
    Goto, Shinya
    Hanna, Michael
    Huber, Kurt
    Husted, Steen
    Lewis, Basil S.
    McMurray, John J. V.
    Pais, Prem
    Pouleur, Hubert
    Steg, Philippe Gabriel
    Verheugt, Freek W. A.
    Wojdyla, Daniel M.
    Granger, Christopher B.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2014, 35 (04) : 224 - 232
12345